Article Details
Retrieved on: 2022-07-19 17:18:02
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
The biopharma plans to meet with the FDA to discuss such a trial. AT-HOME was not powered to evaluate Furoscix for statistically significant efficacy ...
Article found on: www.investorideas.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here